vaginal delivery with vertex presentation. Spontaneous vertex delivery
Conditions
Interventions
Intervention 1: Since beginning of active phase of delivery (50 mm of cervical dilatation and 100 % effacement), patients in group control received 50mg intramuscular pethedine injection. Interventio
Treatment - Drugs
Since beginning of active phase of delivery (50 mm of cervical dilatation and 100 % effacement), patients in group control received 50mg intramuscular pethedine injection.
Intervention group: Since beginning of active phase of delivery (50 mm of cervical dilatation and 100 % effacement), patients in this group received an intravenous solution infusion containing 1000mg
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: inclusion criteria: primigravid singleton women with fullterm pregnancy (gestational age more than 37 weeks based on ultrasound findings) candidated for normal vaginal delivery exclusion criteria:were history of cardiac, liver and renal disease, anti-convulsive medication consumption, malpresentation of fetus, abnormal fetal monitoring during labor and multiple gestations
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Labor pain. Timepoint: Immediately after child birth. Method of measurement: Visual analogue scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Neonatal Apgar score. Timepoint: Immediately and 5 minutes after child birth. Method of measurement: Apgar score table.;Medical complication. Timepoint: 24 hours after delivery. Method of measurement: Study questionarie. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Hassan Abdollahi
Yazd University of Medical Sciences
Outcome results
None listed